MarketCap
Facebook
X
TelegramOrphazyme A/S ROA | ORPH
ROA Jährlich Orphazyme A/S
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|
| -76.99 | -186.72 | -52.02 | - | - | - | - | - | - | - |
Jährliche Entwicklung
Kennzahlen zur Anzeige auswählen
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| -52.02 | -186.72 | -105.24 |
ROA anderer Aktien in der Pharmaeinzelhändler
| Name | ROA | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
Evogene Ltd.
EVGN
|
-39.05 | $ 0.37 | -0.51 % | $ 2.91 M |  Israel |
 |
Armata Pharmaceuticals
ARMP
|
-226.06 | $ 3.72 | -0.8 % | $ 135 M |  USA |
 |
Axsome Therapeutics
AXSM
|
-26.55 | $ 148.5 | 5.34 % | $ 7.39 B | USA |
 |
Champions Oncology
CSBR
|
-4.35 | $ 4.77 | 0.42 % | $ 66 M | USA |
 |
Fennec Pharmaceuticals
FENC
|
-13807.03 | $ 10.7 | 1.13 % | $ 306 M | USA |
|
Forte Biosciences
FBRX
|
-83.81 | $ 76.99 | 0.03 % | $ 997 M | USA |
 |
Immunic
IMUX
|
-404.01 | $ 8.14 | 1.18 % | $ 1.27 B | USA |
 |
DiaMedica Therapeutics
DMAC
|
-53.39 | $ 9.67 | 1.06 % | $ 454 M | USA |
 |
Longeveron
LGVN
|
-221.26 | $ 3.27 | 15.14 % | $ 57.5 B | USA |
 |
Grifols, S.A.
GRFS
|
0.99 | $ 8.85 | 1.03 % | $ 6.02 B |  Spain |
 |
Incyte Corporation
INCY
|
18.49 | $ 122.28 | 1.65 % | $ 23.9 B | USA |
 |
AC Immune SA
ACIU
|
-45.67 | $ 2.26 | -1.53 % | $ 228 M |  Schweiz |
 |
Aldeyra Therapeutics
ALDX
|
-46.97 | $ 0.65 | 2.67 % | $ 39 M | USA |
 |
Aptose Biosciences
APTO
|
-254.37 | - | -45.71 % | $ 1.2 M |  Canada |
 |
Precision BioSciences
DTIL
|
-29.61 | $ 9.12 | -4.0 % | $ 117 M | USA |
 |
AIM ImmunoTech
AIM
|
-241.4 | $ 0.15 | 6.3 % | $ 243 K | USA |
 |
MediWound Ltd.
MDWD
|
-29.6 | $ 13.81 | -2.13 % | $ 376 M | Israel |
 |
Ascendis Pharma A/S
ASND
|
-17.51 | $ 258.99 | 0.94 % | $ 15.7 B |  Danmark |
 |
ANI Pharmaceuticals
ANIP
|
5.42 | $ 71.09 | -0.22 % | $ 1.43 B | USA |
 |
Actinium Pharmaceuticals
ATNM
|
-65.45 | $ 1.59 | 1.27 % | $ 49.6 M | USA |
 |
Autolus Therapeutics plc
AUTL
|
-48.81 | $ 1.24 | -6.06 % | $ 330 M |  Britain |
 |
BridgeBio Pharma
BBIO
|
-78.3 | $ 79.53 | 1.09 % | $ 15.2 B | USA |
 |
BioCryst Pharmaceuticals
BCRX
|
51.32 | $ 7.66 | 1.73 % | $ 1.61 B | USA |
 |
Bicycle Therapeutics plc
BCYC
|
-30.51 | $ 3.69 | -0.14 % | $ 256 M | Britain |
 |
Coherus BioSciences
CHRS
|
65.04 | $ 0.58 | -8.97 % | $ 67.9 M | USA |
 |
Arcutis Biotherapeutics
ARQT
|
-3.73 | $ 28.37 | 3.6 % | $ 3.61 B | USA |
 |
Cellectis S.A.
CLLS
|
-20.82 | $ 1.35 | 21.62 % | $ 135 M |  France |
 |
BeyondSpring
BYSI
|
-3.88 | $ 0.64 | 10.75 % | $ 26.3 M | USA |
 |
Alkermes plc
ALKS
|
9.72 | $ 47.94 | 3.16 % | $ 7.9 B |  Irlanda |
 |
Altimmune
ALT
|
-31.47 | $ 1.94 | -0.21 % | $ 171 M | USA |
 |
Cardiff Oncology
CRDF
|
-0.07 | $ 0.76 | -4.57 % | $ 50.8 M | USA |
 |
Novartis AG
NVS
|
12.59 | $ 160.35 | -1.79 % | $ 311 B | Schweiz |
 |
Citius Pharmaceuticals
CTXR
|
-30.35 | $ 0.49 | -1.36 % | $ 5.42 M | USA |
 |
Arcturus Therapeutics Holdings
ARCT
|
-24.26 | $ 9.32 | -0.75 % | $ 255 M | Israel |
 |
Arrowhead Pharmaceuticals
ARWR
|
-0.12 | $ 49.35 | 0.71 % | $ 6.6 B | USA |
 |
Atara Biotherapeutics
ATRA
|
161.54 | $ 8.27 | 2.1 % | $ 104 M | USA |
 |
Aurinia Pharmaceuticals
AUPH
|
38.21 | $ 16.22 | -0.49 % | $ 2.18 B | Canada |
 |
Cullinan Management
CGEM
|
-49.04 | $ 11.33 | 0.89 % | $ 683 M | USA |
 |
BioNTech SE
BNTX
|
-5.17 | $ 87.68 | 0.54 % | $ 21.2 B |  Germany |
 |
Collegium Pharmaceutical
COLL
|
3.8 | $ 24.8 | 1.35 % | $ 785 M | USA |
 |
Corbus Pharmaceuticals Holdings
CRBP
|
-46.69 | $ 3.99 | 1.53 % | $ 53.1 M | USA |
|
Enlivex Therapeutics Ltd.
ENLV
|
53.1 | $ 1.24 | 3.33 % | $ 56.7 M | Israel |
 |
AnaptysBio
ANAB
|
41.33 | $ 48.73 | 0.72 % | $ 1.41 B | USA |
 |
Assembly Biosciences
ASMB
|
-2.38 | $ 22.36 | 4.73 % | $ 251 M | USA |
 |
Adagene
ADAG
|
-22.5 | $ 2.14 | 4.39 % | $ 126 M |  China |
 |
Benitec Biopharma
BNTC
|
-24.94 | $ 9.47 | 2.05 % | $ 441 M | USA |
 |
Denali Therapeutics
DNLI
|
-44.77 | $ 19.74 | -0.55 % | $ 3.41 B | USA |
 |
Amarin Corporation plc
AMRN
|
-5.78 | $ 11.68 | -0.64 % | $ 4.85 B | Irlanda |
 |
ImmuCell Corporation
ICCC
|
-2.45 | $ 10.19 | -0.7 % | $ 92 M | USA |
 |
Editas Medicine
EDIT
|
-85.81 | $ 2.38 | -4.99 % | $ 211 M | USA |